强心通脉颗粒治疗慢性心衰的临床观察  

Treatment of Cardiac Tongmai Clinical Observation of Chronic Heart Failure

作　　者：海丽[1] 马晓梅[1] 王石[1] 刘自华[1] 

机构地区：[1]北京南苑医院,北京100076

出　　处：《中华中医药学刊》2011年第5期1033-1035,共3页Chinese Archives of Traditional Chinese Medicine

基　　金：国家科技支撑计划资助项目(2007BA120B076);北京市中医药管理局51510工程;中医药特色优势病种的防治和重大疾病中医药科技攻关专题

摘　　要：目的:观察强心通脉颗粒治疗慢性心衰的临床疗效。方法:将90例气滞血瘀型慢性心衰病人随机分为中药治疗组(强心通脉颗粒治疗组)、中西药结合治疗组(口服强心通脉颗粒同时口服常规西药)和西药对照组(常规西药组),治疗4周,观察治疗前后心功能分级、心衰计分及中医症状评分的变化,并采用秩和检验进行统计学分析。结果:中西药结合治疗组疗效最好,优于另外两组,3组比较有统计学意义(P<0.01)。结论:强心通脉颗粒是治疗慢性心衰的有效药物,配合西药治疗可以明显增加疗效。Objective ： To observe the particle treatment of cardiac Tongmai the clinical efficacy of chronic heart failure. Methods ：90 patients with chronic heart failure patients with qi stagnation and were randomly divided into three groups for the Chinese medicine group （cardiac Tongmai granules treatment group ） , the western medicine comparing with TCM group （cardiac Tongmai oral granules while oral conventional western medicine） , Western medicine control group （con- ventional western medicine group）, were treated for 4 weeks, cardiac function before treatment, after treatment, the clas- sification changes, scoring points with heart failure and treatment of TCM symptom score before and after comparisonstudies to determine efficacy. Results ： The efficacy of the western medicine comparing with TCM group is best, better than the other two groups, three groups were statisticaUy significant （ P 〈 0. 01 ）. Conclusion ： Cardiac Tongmai particles is an effective drug for the treatment of chronic heart failure, with the western medicine can significantly increase efficacy.

关 键 词：强心通脉颗粒 慢性心衰 心功能分级 

分 类 号：R259.416[医药卫生—中西医结合]